Moreover, our findings establish that niclosamide potentiates anti-PD-L1 blockade response in vitro as well as in syngeneic tumor models, which correlates with an increased content of TILs and enhanced secretion of Granzyme B and TNF-α from cytotoxic T cells. The gene discussed is GZMB; the disease is neoplasm.